Obesity and prostate cancer

Urology

Volumn 65, Issue 3, 2005, Pages 433-439

  Freedland, Stephen J ^a   Aronson, William J ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; INSULIN; LEPTIN; PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE; TUMOR MARKER;

BODY HEIGHT; BODY MASS; CACHEXIA; CANCER GRADING; CANCER GROWTH; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CARCINOGENESIS; DIABETES MELLITUS; DIET; ESTRADIOL BLOOD LEVEL; HORMONE SYNTHESIS; HUMAN; INSULIN BLOOD LEVEL; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVIEW; TESTOSTERONE BLOOD LEVEL;

EID: 15244354259     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.08.035     Document Type: Review

References (59)

1. K.M. Flegal, M.D. Carroll, C.L. Ogden Prevalence and trends in obesity among US adults, 1999-2000 JAMA 288 2002 1723 1727
2. A.H. Mokdad, E.S. Ford, B.A. Bowman Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 JAMA 289 2003 76 79
3. G.A. Bray The underlying basis for obesity relationship to cancer J Nutr 132 2002 3451S 3455S
4. J. Satia-Abouta, R.E. Patterson, R.N. Schiller Energy from fat is associated with obesity in U.S. men results from the Prostate Cancer Prevention Trial Prev Med 34 2002 493 501
5. A.W. Hsing, J.K. Reichardt, F.Z. Stanczyk Hormones and prostate cancer current perspectives and future directions Prostate 52 2002 213 235
6. R. Kaaks, A. Lukanova, B. Sommersberg Plasma androgens, IGF-1, body size, and prostate cancer risk a synthetic review Prostate Cancer Prostatic Dis 3 2000 157 172
7. L.N. Kolonel, A.M. Nomura, R.V. Cooney Dietary fat and prostate cancer current status J Natl Cancer Inst 91 1999 414 428
8. P.C. Dagnelie, A.G. Schuurman, R.A. Goldbohm Diet, anthropometric measures and prostate cancer risk a review of prospective cohort and intervention studies BJU Int 93 2004 1139 1150
9. E.A. Platz Energy imbalance and prostate cancer J Nutr 132 2002 3471S 3481S
10. S.O. Andersson, A. Wolk, R. Bergstrom Body size and prostate cancer a 20-year follow-up study among 135,006 Swedish construction workers J Natl Cancer Inst 89 1997 385 389
11. M.B. Veierod, P. Laake, D.S. Thelle Dietary fat intake and risk of prostate cancer a prospective study of 25,708 Norwegian men Int J Cancer 73 1997 634 638
12. A. Engeland, S. Tretli, T. Bjorge Height, body mass index, and prostate cancer a follow-up of 950000 Norwegian men Br J Cancer 89 2003 1237 1242
13. S.D. Putnam, J.R. Cerhan, A.S. Parker Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men Ann Epidemiol 10 2000 361 369
14. A.G. Schuurman, R.A. Goldbohm, E. Dorant Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study Am J Epidemiol 151 2000 541 549
15. A.S. Whittemore, L.N. Kolonel, A.H. Wu Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada J Natl Cancer Inst 87 1995 652 661
16. T.I. Nilsen, L.J. Vatten Anthropometry and prostate cancer risk a prospective study of 22,248 Norwegian men Cancer Causes Control 10 1999 269 275
17. A. Nomura, L.K. Heilbrun, G.N. Stemmermann Body mass index as a predictor of cancer in men J Natl Cancer Inst 74 1985 319 323
18. E. Giovannucci, E.B. Rimm, Y. Liu Body mass index and risk of prostate cancer in U.S. health professionals J Natl Cancer Inst 95 2003 1240 1244
19. E. Giovannucci, E.B. Rimm, M.J. Stampfer Height, body weight, and risk of prostate cancer Cancer Epidemiol Biomarkers Prev 6 1997 557 563
20. S. Rohrmann, W.W. Roberts, P.C. Walsh Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer Prostate 55 2003 140 146
21. S.J. Freedland, W.J. Aronson, C.J. Kane Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer a report by the Shared Equal Access Regional Cancer Hospital database study group J Clin Oncol 22 2004 446 453
22. C.L. Amling, R.H. Riffenburgh, L. Sun Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy J Clin Oncol 22 2004 439 445
23. C.L. Amling, C.J. Kane, R.H. Riffenburgh Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy Urology 58 2001 723 728
24. C. Rodriguez, A.V. Patel, E.E. Calle Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States Cancer Epidemiol Biomarkers Prev 10 2001 345 353
25. E.E. Calle, C. Rodriguez, K. Walker-Thurmond Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 2003 1625 1638
26. M. Okasha, P. McCarron, J. McEwen Body mass index in young adulthood and cancer mortality a retrospective cohort study J Epidemiol Community Health 56 2002 780 784
27. J.C. Will, F. Vinicor, E.E. Calle Is diabetes mellitus associated with prostate cancer incidence and survival? Epidemiology 10 1999 313 318
28. K. Steenland, S. Nowlin, S. Palu Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity Cancer Epidemiol Biomarkers Prev 4 1995 807 811
29. E. Giovannucci, E.B. Rimm, M.J. Stampfer Diabetes mellitus and risk of prostate cancer (United States) Cancer Causes Control 9 1998 3 9
30. K. Zhu, I.M. Lee, H.D. Sesso History of diabetes mellitus and risk of prostate cancer in physicians Am J Epidemiol 159 2004 978 982
31. E. Weiderpass, W. Ye, H. Vainio Reduced risk of prostate cancer among patients with diabetes mellitus Int J Cancer 102 2002 258 261
32. A.W. Hsing, S. Chua Jr, Y.T. Gao Prostate cancer risk and serum levels of insulin and leptin a population-based study J Natl Cancer Inst 93 2001 783 789
33. A.L. Coker, M. Sanderson, W. Zheng Diabetes mellitus and prostate cancer risk among older men population-based case-control study Br J Cancer 90 2004 2171 2175
34. J.S. Hubbard, S. Rohrmann, P.K. Landis Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore Longitudinal Study of Aging Urology 63 2004 253 258
35. S. Bonovas, K. Filioussi, A. Tsantes Diabetes mellitus and risk of prostate cancer a meta-analysis Diabetologia 47 2004 1071 1078
36. M. Iwamura, P.M. Sluss, J.B. Casamento Insulin-like growth factor I action and receptor characterization in human prostate cancer cell lines Prostate 22 1993 243 252
37. D. Gunnell, S.E. Oliver, T.J. Peters Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men Br J Cancer 88 2003 1682 1686
38. S.Y. Nam, E.J. Lee, K.R. Kim Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone Int J Obes Relat Metab Disord 21 1997 355 359
39. M.D. Holmes, M.N. Pollak, S.E. Hankinson Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations Cancer Epidemiol Biomarkers Prev 11 2002 862 867
40. J.M. Chan, M.J. Stampfer, E. Giovannucci Plasma insulin-like growth factor-I and prostate cancer risk a prospective study Science 279 1998 563 566
41. P. Stattin, A. Bylund, S. Rinaldi Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk a prospective study J Natl Cancer Inst 92 2000 1910 1917
42. A. Wolk, C.S. Mantzoros, S.O. Andersson Insulin-like growth factor 1 and prostate cancer risk a population-based, case-control study J Natl Cancer Inst 90 1998 911 915
43. T. Shaneyfelt, R. Husein, G. Bubley Hormonal predictors of prostate cancer a meta-analysis J Clin Oncol 18 2000 847 853
44. A.G. Renehan, M. Zwahlen, C. Minder Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk systematic review and meta-regression analysis Lancet 363 2004 1346 1353
45. R. Shi, H.J. Berkel, H. Yu Insulin-like growth factor-I and prostate cancer a meta-analysis Br J Cancer 85 2001 991 996
46. C.S. Mantzoros, A. Tzonou, L.B. Signorello Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia Br J Cancer 76 1997 1115 1118
47. J.M. Chan, M.J. Stampfer, J. Ma Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer J Natl Cancer Inst 94 2002 1099 1106
48. K. Woodson, J.A. Tangrea, M. Pollak Serum insulin-like growth factor I tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men Cancer Res 63 2003 3991 3994
49. H.A. Ismail, M. Pollak, H. Behlouli Serum insulin-like growth factor (IGF)-1 and IGF-binding protein-3 do not correlate with Gleason score or quantity of prostate cancer in biopsy samples BJU Int 92 2003 699 702
50. A. Scorilas, M. Plebani, S. Mazza Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA Prostate 54 2003 220 229
51. G.J. Bubley, S.P. Balk, M.M. Regan Serum levels of insulin-like growth factor-1 and insulin-like growth factor-1 binding proteins after radical prostatectomy J Urol 168 2002 2249 2252
52. O. Ali, P. Cohen, K.W. Lee Epidemiology and biology of insulin-like growth factor binding protein-3 (IGFBP-3) as an anti-cancer molecule Horm Metab Res 35 2003 726 733
53. J.A. Yanovski, S.Z. Yanovski Recent advances in basic obesity research JAMA 282 1999 1504 1506
54. R.V. Considine, M.K. Sinha, M.L. Heiman Serum immunoreactive-leptin concentrations in normal-weight and obese humans N Engl J Med 334 1996 292 295
55. P. Stattin, S. Soderberg, G. Hallmans Leptin is associated with increased prostate cancer risk a nested case-referent study J Clin Endocrinol Metab 86 2001 1341 1345
56. M. Onuma, J.D. Bub, T.L. Rummel Prostate cancer cell-adipocyte interaction leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase J Biol Chem 278 2003 42660 42667
57. P. Stattin, R. Kaaks, R. Johansson Plasma leptin is not associated with prostate cancer risk Cancer Epidemiol Biomarkers Prev 12 2003 474 475
58. S. Chang, S.D. Hursting, J.H. Contois Leptin and prostate cancer Prostate 46 2001 62 67
59. K. Saglam, E. Aydur, M. Yilmaz Leptin influences cellular differentiation and progression in prostate cancer J Urol 169 2003 1308 1311